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ABSTRACT 
Antimicrobial resistance is being identified as one of the major threats in the health sector 
and to humans. The main reason of development of the resistance is established as 
acceleration of the natural evolution of the bacteria due to unnecessary constraints 
provided by the antimicrobial agents. After exploiting and exhausting the available 
antibiotics, development of new antibiotics is proven to be an expensive and difficult task 
and therefore alternative solutions such as use of nanoparticles, bacteriophage, natural 
ingredients, and new mechanisms such as quorum sensing ability were staged. It is 
important to identify the mechanism by which each of these new ingredients act in 
bacteria and reaction in the host environment to avoid similar misuses and creation of 
resistance. This review focuses on summarizing action mechanisms of antibiotics and 
resistance mechanisms of microbes and gathering probable action and resistance 
mechanisms of herbal ingredients. Antibiotic action is mainly obtained by inhibiting a 
bacterial structure or specific metabolic activity that is necessary for survival of bacteria. 
Some plants in contrast do not focus on inhibiting bacteria but minimizing the effects on 
host by nullifying the toxins and improving the immunity. Some other plants can disrupt 
the communication between bacteria and biofilm formation. One of the most important 
ability of some herbal ingredients is to overpass the resistance and they are called 
inhibitors. With the inhibitors there are new possibilities of reintroducing antibiotics. 
Plants with bactericidal capacity must use carefully to avoid creating resistance and 
should conduct further research for calculating proper dosages. 
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INTRODUCTION 
World Health Organization has issued an 
ultimatum on human health by highlighting the 
impending peril of accelerated Antibiotic resistance 
due to misuse of Antibiotics. The natural process of 
evolution which created the bacteria resistance to 
Antibiotic has increased its phase by several folds 
due to unnecessary and incorrect use of Antibiotics 
by the individuals, health professionals, agriculture 
and poultry sector.[1,2] New developments in 
antibiotics are slow[3] and not expected to be effective 
against most dangerous bacteria. Occurrence of multi 
drug resistance is common among most 
opportunistic and pathogenic bacteria.[4] 
European Commission action plan against the 
rising threats from antimicrobial resistance (AMR) 
includes the “promotion of the appropriate use of 
antimicrobial agents in human and veterinary 
medicine, the prevention of microbial infections and 
their spread, the development of new antimicrobials, 
alternatives for treatment or diagnostic tools, and the 
harmonization of surveillance systems”.[5] 
Prevalence of Antimicrobial Resistance 
Many survey studies have been conducted in 
recent past demonstrating the failure of Antibiotics 
or improved antimicrobial resistance. Study on fecal 
Escherichia coli isolated from healthy volunteers 
from developing countries shows highest 
percentages of resistance in the urban populations of 
Asia and South America.[6] 
Causes of AMR in developing countries are 
different than those in developed contries. Common 
causes are acceleration of natural resistance by 
misuse and over use for various reasons including 
human consumption, farming and poultry. Specific 
reasons in developing countries can be identified in 
every step involved from manufacturer to the 
individual. Lack of drug quality and dosage by 
production, easy access due to lack of regulations, 
misuse by health professionals by wrong 
prescriptions and use of broad spectrum 
antimicrobial agents, lack of effective surveillance 
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systems, and lack of up to date information about 
AMR patterns.[7] In a Lebanese study, it was shown 
that in 52% of cases, the prescription dose was 
inappropriate while 63.7% of physicians prescribed 
antibiotics with wrong duration of treatment.[8] 
Some studies focus on the danger of using 
traditional or alternative therapy as first line 
treatments for infections due to unknown 
composition and potency of these medicines. They 
may have a potential role in AMR if the dosage is not 
enough for the intended action while creating a multi 
facade common resistance such as reducing the 
permeability of the cell membrane.[7] 
Identifying the method/s of spreading of 
Antibiotic Resistance Bacteria (ARB) and Antibiotic 
Resistance Genes (ARGs) are also important in 
provenance. Many studies have been done on this 
subject and in one study that had been conduction by 
Graham Environmental Sustainability Institute at the 
University of Michigan shows water distribution 
systems could serve as an incubator for growth of 
certain ARB populations and as an important 
reservoir for the spread of antibiotic resistance to the 
opportunistic pathogens.[9] Similar study had been 
done in Portugal regarding waste water and purified 
waste water and the conclusion was ARB was not 
eliminated by the purification process.[10] 
Few examples of global epidemiology of AMR 
among disease causing bacteria is being listed and 
Neisseria gonorrhoeae is estimated as 60 million 
cases per year and Haemophilus ducreyi (Chancroid) 
is 7 million new cases per year around the globe. 
Quinolone resistance gonococci was first identified in 
1992 and by the year of 1996, 50% of resistance was 
exhibited in Hong Kong, China, Korea, Cambodia, and 
the Philippine.[11] Prevalence of Macrolide Resistance 
in Streptococcus pneumoniae in United States in 
1994-1995 ranged from 2.1% to 23% in 30 different 
medical centers.[12] In 2013 an estimated number of 
affected numbers of people with multi drug resistant 
tuberculosis was estimated at 630,000 and cases 
have been reported from more than 80 countries.[2] 
Action and Resistance Mechanisms of Antibiotics 
Action mechanisms from which antibiotics 
act against microbes are important for understanding 
resistance created by bacteria. 
Antibiotic action mechanisms 
Basic Anatomy of Bacteria cell wall 
Basic anatomy of bacteria cell wall is 
important for understanding the mechanisms of 
action and resistance of Antibiotics. Bacteria are 
divided into two major groups depending on their 
cell wall structure and these differences caused 
differences in staining of the bacteria. A gram–
positive bacterium consists of inner cytoplasmic 
membrane and outer cell wall made of thick layer of 
peptidoglycan. Gram- negative bacteria consist of 
thin peptidoglycan cell wall that is covered by the 
outer membrane and inner cytoplasmic membrane. 
Even though this additional membrane layer 
prevents the entering of foreign matters to the 
bacterium, channels referred as porins allows 
passage of some chemicals shush as specific drugs. 
Membranes are made of lipids. Space between 
membranes is called periplasm. Cell walls provide the 
shape and act against the mechanical and osmotic 
stress. Cell membrane keep ion balance of the cell as 
well as content of the bacteria contained inside.[13,14] 
Antibiotic action is mainly obtained by the inhibition 
of bacterial structure or metabolic activities.[14] 
Inhibit cell wall synthesis 
Cell wall made of peptidoglycan consists of 
long sugar polymers. The peptidoglycans cross-link 
to from the glycan strand by the action of 
transglycosidases enzyme. Then peptide chains 
extend from the sugars from the chain to another to 
make cross links between peptides. In the presence 
of penicillin binding proteins, a portion chain is cross 
linked by glycine residues and strengthens the cell 
wall. Beta- lactam antibiotics are targeting penicillin 
binding proteins (PBP). β-lactam ring mimics the part 
of the peptide chain that is normally bind to PBP and 
interfere with the synthesis of peptidoglycan and 
leads to the lysis of bacterium.[15,16] 
Inhibit protein synthesis 
Synthesis of protein in bacteria is similar to 
that of any animal cell and occurs through 
transcription and translation process. The bacterial 
70S ribosome is made of two ribonucleo protein 
subunits known as 30S and 50S subunits. Protein 
biosynthesis of bacteria is inhibited by targeting 
these subunits. 30S subunits are inhibited by 
Aminoglycosides (AG’s). Positively charged AG’s 
enter the cell wall via membrane actively in aerobic 
conditions and interfere with the m-RNA translation 
of 30S unit. In anaerobic conditions AG’s needs to be 
combined with the β-lactam and glycopeptides for an 
easy penetration of the cell wall. Tetracyclines are in 
this category. 50S subunits are inhibited by the 
chloramphenicol by interfering with the t-RNA 
binding site of the 50S unit. Macrolides affect the 
translocation of the 50S ribosomal subunit and leads 
to premature detachment of incomplete peptide 
chains. Oxazolidinones interfere with the several 
stages of protein synthesis by binding to 50S subunit 
and by inhibition of peptidyl t- RNA.[17-20] 
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Inhibit DNA replication 
Quinilones inhibits the bacterial DNA gyrase 
and damage the double strand DNA. This is highly 
effective in Gram positive bacteria in which major 
target of action is topoisomerase IV having greater 
affinity to fluoroquinolones that nicks and separate’s 
daughter DNA strand after DNA replication.(21) 
Inhibits the Folic acid metabolism  
Sulfonamides and trimethoprim inhibits 
specific steps in folic acid metabolism by inhibiting 
the specialized enzymes. 
Biochemical resistance mechanisms 
Antibiotic resistance can be either intrinsic 
(natural) or acquired.[14] 
Antibiotic inactivation 
β-lactamases, aminoglycoside – modifying 
enzymes, and chloramphenicol acetyltransferase 
(AACs) are produced by the bacteria and capable of 
inactivating the antibiotics. 
β-lactamases are classified according to 
structure and function as Class A, B, C and D. Class A 
found in members of Enterobacteriaceae and 
resistant to penicillins, third generation 
cephalosporin etc, but those are sensitive to 
cephamycins and carbapenems such as clavulanic 
acid. Class B is resistant to clavulanate, aztreonam, 
and carbapenems. Class C are called 
cephalosporinases and produced by all Gram- 
negative bacteria except Salmonella and Klebsiella. 
These classes are resistant to all β-lactams except 
carbapenems and they are not inhibited by 
clavulanate. Class D found in Enterobacteriaceae and 
in P. aeruginosa. They are resistant to penicillin, 
Cloxacillin, Oxacillin, and Methicillin. They can be 
inhibited by sodium chloride.[18,22-24] 
Target modification 
This can occur due to natural mutation of 
binding sites. Even slightest changes can affect the 
sensitivity due to specific target mechanisms. 
Alteration of PBP, 30S binding site or cell wall 
precursors alteration, and DNA gyrase mutations are 
some examples for this.[22-25] 
Altered permeability 
Decreased number of porin channels reduces 
the entry of β-lactam antibiotics and FQ to the cell. 
Pseudomonas aeruginosa has acquired resistance to 
all the antibiotic classes via low outer membrane 
permeability.[23,24,26] Efflux mechanism of the bacteria 
includes where inner cytoplasmic membrane 
proteins remove or export antibiotics from the cell at 
increased speeds before they reach the target. 
Antibiotics of all the classes except polymyxin can be 
export through efflux system and can be specific or 
multidrug resistant.[22] Study on multi drug resistance 
Mycobacterium tuberculosis shows up regulation of 
Efflux gene by identifying relevant point mutations 
that create resistance to variety of antibiotics.[27] 
Bypassing the metabolic pathway 
Bacteria resistance acquired by avoiding 
inactivation of specific enzymes that can obstruct 
bacterial metabolic actions is known as bypassing 
metabolic pathway. Some trimethoprim and 
sulfonamide resistant bacteria shows this variety of 
resistance by producing a second enzyme that can 
achieve the same action in metabolic pathway but 
has lower affinity to target specific enzyme 
inactivation of given antibiotic.[4] 
Biocides and biocides antibiotic cross resistance  
Biocides do not have a specific target in the 
bacteria cell. Enzyme resistance and target 
modification are less likely to occur due to this 
reason. Resistance occurs due to improved tolerance 
and non specific changes such as improved lack of 
permeability, improvement of efflux capacity. Eg; 
triclosan.[24] 
Alternative Therapies 
Due to an increase of antimicrobial resistance 
(AMR) for traditional antibiotics and lack of 
development of new antibiotics, alternative therapies 
are considered for controlling microbial growth and 
virulence without gaining resistance.  
Nanoparticles as potential antimicrobials 
Nanosized (1-1000 nanometers) organic and 
inorganic particles are use as antimicrobial agents 
due to specific physicochemical properties such as 
large surface volume ratio provided by nanoparticle 
size in comparison with the regular chemical 
antimicrobial agents. Metallic nanoparticles such as 
copper, aluminum, gold, silver, magnesium, zinc and 
titanium work through various mechanisms as 
bactericidal chemicals. Nano size and large surface 
area improve the interaction with the microorganism 
and some resistance techniques such as permeability 
is not an issue for nanoparticles. For example, silver 
has a high affinity towards the sulphur and 
phosphorus and large content of sulphur containing 
protein of the cell membrane and phosphorus in DNA 
attracts Ag+ particles and therefore it increases the 
permeability and then destruction of the cells. This is 
purely chemical and physical reaction and enzymes 
have little to do with it. Thus development of 
resistance is difficult. However host cell may have 
similar reactions to the nanoparticles and therefore 
suitable particle size and quantities should be 
carefully calculated.[28] 
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Using bacteriophage 
Specific bacteriophages that can invade and 
induce the lysis of pathogenic bacteria are used as a 
new treatment technique.[29] 
Quorum Sensing Inhibitors (QSI) 
QSI can decrease the bacterial virulence by 
disrupting the communication system between 
bacteria without killing the cells and therefore reduce 
the unnatural selective pressure on bacteria and will 
decelerate the phase of evolution of AMR.[30] 
Opportunistic and pathogenic bacteria use QS system 
to coordinate their virulence expression. 
Probiotics 
Use of probiotics or a fecal transplant therapy 
(FTT) is uncommon but emerging practice in which 
fecal matter from pathogen free healthy donors are 
use to repopulate the microbiota of a recipient.[31] 
Herbal treatments 
Bacteria cannot easily develop a resistance to 
plant materials due to complex and multiple 
chemicals that are introduced by the plant materials 
and therefore multiple assaults produce by the 
variety and due to lack of repetitions of the 
treatments.[32] However, some research data shows 
the ability of bacteria to develop resistance during 
long term use of isolated herbal materials such as 
essential oil or powders. Also some bacteria may 
have natural resistance to some plant materials.[33] 
Plants Action Mechanisms 
Antimicrobial resistance modifying agents MDR 
inhibitors 
MDR bacteria are capable of developing 
safety mechanisms for a number of structurally and 
chemically unrelated medical compounds. The ability 
of modifying one or all of this chemical compounds to 
break this barrier in some herbal ingredients are 
been observed and these drugs that can work with 
antibiotics in synergism are called MDR inhibitors.[34] 
Plants as antibiotic resistance modifying agents/ 
Efflux pumps Inhibitors 
As previously mentioned many antimicrobial 
agents work by destroying the cells and therefore 
creating a selective pressure towards creating 
antimicrobial resistance. Efflux pumps are one of the 
common mechanisms developed by bacteria towards 
resistance. Due to non selective efflux process they 
are capable of creating multi drug resistance. Some 
plants material has the natural capacity to inhibit 
those pumps and therefore known as antibacterial 
resistance modifying agents. Barberine is one of the 
successful natural ingredient that has been used at a 
sub- inhibitory as an Efflux pump inhibitor to help re-
introduction of antibacterial agent back to the 
bacterial cells.[35] 
Quorum sensing inhibiting action 
Plants have lived with micro organisms as 
long as they existed and battled against pathogenic 
bacteria and survived in balance without killing or 
being killed. Therefore many have suspected they 
might have developed methods to manipulate the 
pathogenic bacteria into coexistence. QS system 
inhibitors are one of these mechanisms developed by 
nature. There are some chemical compounds that can 
inhibit QS, but most of the available QS inhibitors are 
natural products. N-acylhomoserine lactonase 
enzyme from bacillus sp., is capable of hydrolyzing 
lactone bond of the N-acelhomoserine signaling 
compound and thus disrupting the QS ability of other 
bacteria.[36,37] This method do not induce selective 
pressure which may give rise to acceleration of 
bacterial resistance. Attenuation Pseudomonas 
aeruginosa virulence by medicinal plant extracts is an 
example for the possibility of involvement of QS 
inhibition.[38] Studying plant volatiles against QS 
using Chromobacterium violaceum and Pseudomonas 
aeruginosa shows positive results by inhibiting QS 
with twenty two compounds while enhancing QS 
with seven compounds.[39] 
Inhibition of biofilm formation 
Biofilm formation is considered as an 
antimicrobial resistance method developed by 
bacteria. Plant derived materials role on inhibiting 
biofilm formation and related genes changes shows 
possibility of reduction of virulence factors by plant 
materials. One study shows epigallocatechin- gallate 
(EGCG) from tea is capable of inhibiting biofilm 
formation and reducing hemolytic activity of food 
borne pathogen Listeria monocytogenes in vitro 
conditions. Also in the same study observations 
include up regulation of the virulence genes, quorum 
sensing genes and transcription activator SOS genes 
and positive relationship between QS gene and 
biofilm formation.[40] 
Antitoxin 
Using plant compounds against bacteria 
without killing them (Sub- inhibitory levels) is a 
technique to reduce the development antimicrobial 
resistance while reducing the adverse effect to the 
patient. Carvacrol, a monoterpenoid from oregano 
and thyme oil and Trans- cinnamaldehyde, an 
aromatic aldehyde from cinnamon bark test against 
Clostridium difficile anaerobic gut bacteria proves to 
be effective in inhibiting toxin production and also 
affecting the related gene.[41] Aegle marmelos unripe 
fruit affect the production of cholera toxin E.coli heat 
labile toxin and their binding to gut receptors. Also it 
significantly reduce the bacterial adherence and 
invasion in the gut epithelium.[42] Sub–inhibitory 
concentration of Eugenol subsides the toxic 
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Hemolytic and Necrotic effect induced by the 
Staphylococcus aureus.[35] Immobilization of microbial 
toxin using plants and food are widely tested and 
succeeded in vitro conditions. However introducing 
these compound to host body in accurate non toxic 
but effective dosages to avoid widely spread 
symptoms and discomfort caused by infection is yet 
to be studied.[43] 
Immunomodulatory/Stimulant activity 
Immuno-stimulants are a type of immuno-
modulatory compounds that can enhance body 
resistance against infections. The compounds that do 
not have any microbial activities or little but can help 
the immune system to fight against the infection and 
therefore render the microbial activity minimum and 
enhance the action of active drugs are considered as 
immuno-stimulants. Herbal ingredients that are well 
known for enhancing strength and vitality such as 
Withania somnifera and Tinospora cordifolia show 
immuno-stimulatory activity in vitro. However 
combine test in clinical settings have not done.[44] 
Antimicrobial resistance is resulted from 
misuse of medicine and creating a selective pressure 
on microbes. Due to current dilemma of possibility of 
the complete failure of existing medicines it has 
become necessity to explore and invent new 
treatment methods, invention of new molecules that 
can work through different mechanisms, alteration of 
protective responds that has raised from microbes, 
and methods to improve human resistance to the 
pathogenic bacteria.[3] 
Use of herbal or natural treatment for one of 
those purposes is a popular research area. Invention 
of possible natural microbial killing agents, 
understanding their mechanisms, using those 
microbial agents without creating selective pressure, 
inventing natural agents that are capable of 
enhancing immune response in humans, using herbal 
drugs for altering or bypassing resistance 
mechanisms have been studied to a certain extent.  
However the possibility of creating herbal 
drug resistance through overuse due to falls safety 
feeling that comes with natural terms cannot be 
ignored.[33] Also the possibility of Antibiotics having 
different outcome than in inhibition in sub-inhibitory 
concentration via alteration of protein transcription 
cannot be ignored. Those outcomes changes with the 
media bacteria is grown and the presence of internal 
factors that affect outer environment like biofilm 
formation, and other external and environmental 
factors.[45] 
Other aspects such as cultivation possibilities, 
cost effectiveness, environmental hazards are also to 
be considered on the development of potent natural 
products. 
CONCLUSIONS  
In conclusion natural or plant derivatives can 
be the solution for the bacterial infectious diseases in 
failure of synthetic antibiotics. However 
identification and use of those natural ingredients are 
of utmost importance to avoid exploitation of the 
plants as well as to avoid exploitation of medicinal 
aspects of the plants. 
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